Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
To compare the change in glycemic control from baseline to endpoint (last available
posttreatment assessment) as measured by HbA1c in pediatric subjects with type 2 diabetes
receiving either glimepiride or metformin as monotherapy.